ABCD² Score for TIA

ABCD2 (TIA Risk)

Predicts short-term stroke risk after a transient ischemic attack

ABCD² Score for TIA

ABCD2 (TIA Risk)

Predicts short-term stroke risk after a transient ischemic attack

Age
Patient's age
Blood Pressure
At the time of presentation
Clinical Features
Type of symptoms
Duration of Symptoms
Length of TIA episode
Diabetes
History of diabetes
ABCD² Score 0Low risk (≤ 3, 2-day stroke risk 1%)
0/5 answered · tap options to update (0-7)

Instructions

The ABCD2 score helps estimate the short-term risk of stroke following a Transient Ischemic Attack (TIA). It assigns points based on five clinical factors: Age, Blood Pressure, Clinical Features, Duration, Diabetes.

Use this score in the emergency setting or outpatient clinic when evaluating a patient with recent TIA symptoms. The tool should complement, not replace, clinical judgment. High-risk patients should undergo urgent imaging and be referred for stroke prevention.

Overview
When to use
Why use
Evidences

Interpretation:

Criteria

Response

Points

Age ≥ 60

Yes/No

+1

Blood Pressure ≥ 140/90 mmHg

Yes/No

+1

Clinical Features

Unilateral weakness

-

+2

Speech disturbance (no weakness)

-

+1

Other symptoms

-

0

Duration of symptoms

Less than 10 minutes

-

0

10 to 59 minutes

-

+1

60 minutes or more

-

+2

History of Diabetes

Yes/No

+1

 

Total score ranges from 0 to 7:

  • 0–3: Low risk

  • 4–5: Moderate risk

  • 6–7: High risk

A multicenter meta-analysis including nearly 14,000 TIA patients found that an ABCD2 score ≥4 had high sensitivity (86.7%) for predicting stroke within 7 days, supporting its use for risk stratification and urgent triage, but its specificity is modest (35.4%), and it’s less reliable for distinguishing TIA mimics or identifying carotid stenosis/atrial fibrillation.

https://pmc.ncbi.nlm.nih.gov/articles/PMC4520819/

The ABCD2 is recommended by several international guidelines for early risk stratification post-TIA, but studies also highlight its limitations and advise combining score results with expert clinical judgment and imaging.

https://pmc.ncbi.nlm.nih.gov/articles/PMC2753856/

More recent studies confirm its calibrated prediction in both anterior and posterior circulation TIA, with similar short-term risk assessment performance.

https://www.nature.com/articles/s41598-023-41260-9

Overview
When to use
Why use
Evidences

The ABCD2 score is a fast and effective risk stratification tool used to identify individuals at elevated risk of stroke in the days immediately following a TIA. A TIA, often called a “mini-stroke,” causes temporary neurological symptoms due to reduced blood flow but resolves without permanent damage.

However, TIAs are often a warning sign for a more serious stroke. Studies show that the highest risk occurs in the first 48 hours. Early intervention can reduce this risk significantly.

The ABCD2 score was developed to assist healthcare professionals in identifying which patients need urgent evaluation and treatment. It is commonly used in emergency departments, urgent care clinics, and primary care settings.

Its five criteria are based on the most predictive clinical features of early stroke following TIA. Patients scoring 4 or higher should be considered for immediate brain imaging, vascular studies, and possibly hospital admission. The score also helps determine the need for starting antiplatelet therapy, statins, or referral to neurology.

Conditions where ABCD2 is especially relevant:

  • Sudden weakness or speech loss that resolved within minutes

  • Transient vision loss in one eye

  • Temporary numbness or confusion

  • First-time unexplained neurological episodes

Overview
When to use
Why use
Evidences

Interpretation:

Criteria

Response

Points

Age ≥ 60

Yes/No

+1

Blood Pressure ≥ 140/90 mmHg

Yes/No

+1

Clinical Features

Unilateral weakness

-

+2

Speech disturbance (no weakness)

-

+1

Other symptoms

-

0

Duration of symptoms

Less than 10 minutes

-

0

10 to 59 minutes

-

+1

60 minutes or more

-

+2

History of Diabetes

Yes/No

+1

 

Total score ranges from 0 to 7:

  • 0–3: Low risk

  • 4–5: Moderate risk

  • 6–7: High risk

A multicenter meta-analysis including nearly 14,000 TIA patients found that an ABCD2 score ≥4 had high sensitivity (86.7%) for predicting stroke within 7 days, supporting its use for risk stratification and urgent triage, but its specificity is modest (35.4%), and it’s less reliable for distinguishing TIA mimics or identifying carotid stenosis/atrial fibrillation.

https://pmc.ncbi.nlm.nih.gov/articles/PMC4520819/

The ABCD2 is recommended by several international guidelines for early risk stratification post-TIA, but studies also highlight its limitations and advise combining score results with expert clinical judgment and imaging.

https://pmc.ncbi.nlm.nih.gov/articles/PMC2753856/

More recent studies confirm its calibrated prediction in both anterior and posterior circulation TIA, with similar short-term risk assessment performance.

https://www.nature.com/articles/s41598-023-41260-9

Frequently Asked Questions

Features and Services FAQs

Discover the full range of features and services we offer and how to use them.

What does the ABCD2 score measure?+
What is a TIA?+
What is considered a high ABCD2 score?+
Can it be used in primary care?+
Does a low score mean no risk?+
Is imaging needed after a TIA?+

Ready to Transform Your Practice?

Join thousands of clinicians saving hours daily with AI-powered documentation.

14-day free trial • No setup fees

Ready to Transform Your Practice?

Join thousands of clinicians saving hours daily with AI-powered documentation.

14-day free trial • No setup fees

Ready to Transform Your Practice?

Join thousands of clinicians saving hours daily with AI-powered documentation.

14-day free trial • No setup fees

DocScrib

AI-powered medical documentation platform revolutionizing clinical workflows through intelligent patient management and secure documentation.

© 2025 DocScrib. All rights reserved.

DocScrib

AI-powered medical documentation platform revolutionizing clinical workflows through intelligent patient management and secure documentation.

© 2025 DocScrib. All rights reserved.

DocScrib

AI-powered medical documentation platform revolutionizing clinical workflows through intelligent patient management and secure documentation.

© 2025 DocScrib. All rights reserved.